Recent Articles

• Rani Therapeutics Secures $60.3 Million from Private Placement
• Wrap Technologies Unveils Game-Changing Drone Interdiction Tool
• Caledonia Mining Updates Shareholder Structure and Changes
• UCLOUDLINK Group's Innovative Movement Towards Pet-Tech Expansion
• SL Green Realty Corp. Declares Monthly Dividend Payment
• Prelude Therapeutics Welcomes Katina Dorton to Board
• StorageVault's Strategic Growth and Financial Success in Management
• PharmaCorp Rx Inc. Announces Strategic Funding Prospectus Launch
• Rani Therapeutics Secures $60.3 Million in Private Investment
• Ally Financial Shows Strength in Latest Financial Update
• Ally Financial's Impressive Q3 Performance Unveiled
• Zenith Bank PLC Shines Bright at 2025 Global Brands Awards
• Aker Carbon Capture ASA Concludes Extraordinary Meeting and Liquidation
• Introducing the TrueCool Collection: A New Era in Comfort
• Aker Carbon Capture ASA's Final Meeting: A Journey Concluded
• Guardian Capital's October 2025 ETF Cash Distributions Explained
• Celebrating a Legacy: Tom Mitchell's Impact on Fabrinet's Growth
• Exciting Developments at Climb Bio for 2025 Kidney Week
• Foresight VCT PLC's Strategic Share Buyback Announcement
• XORTX Pursues Innovative Kidney Fibrosis Therapies with New Deal
• Sanofi Aims for Rezurock Approval in Chronic GVHD Treatment
• Exxon Mobil Strengthens Indian Market with Oil Supply
• EU Committee Backs Sanofi’s Wayrilz for Immune Thrombocytopenia
• Analysts See $8 Trillion Opportunity Through AI Growth
• Three Energy Stocks to Consider for Investment Growth
• Comerica's Thriving Growth Shown in Recent Financial Results
• Laminated Glass Market Expected to Reach $54.50 Billion Soon
• Bank of America to Redeem €1.75 Billion in Senior Notes Soon
• Boston Scientific Broadens Chronic Pain Solutions with Nalu Deal
• Illuminating Artistry: Manar Abu Dhabi's Creative Showcase
• Empowering ASEAN's Zero-Carbon Future with Smart Technologies
• Natural Grocers Hosts Family Halloween Festivities This Fall
• Celebrating Seven Years of Legalization: Tilray's Success Story
• Fabrinet Transitions Leadership as Founder Tom Mitchell Retires
• Sight Sciences Secures Medicare Pricing for TearCare System
• XORTX's Strategic Acquisition of VB4-P5 to Combat Kidney Disease
• Tonix Pharmaceuticals Showcases TNX-801 Vaccine Data
• Major Drilling Launches Normal Course Issuer Bid Program
• Eledon Pharmaceuticals' Promising Results from BESTOW Trial Unveiled
• Climb Bio Showcases Promising Developments in Nephrology Research
• Leadership at Chicago Atlantic Invests in Company Growth
• Sanofi's Wayrilz Receives Positive CHMP Recommendation for ITP Treatment
• Foresight Ventures VCT PLC Announces Equity Allocation Details
• Resilience Enhances Tech E&O Insurance for Large Clients
• Saudi Arabia Pursues Strategic Defense Agreement with US
• Doral Renewables' CEO Nick Cohen Receives Prestigious Honor
• Comerica's Strong Performance in Q3 2025 Financial Results
• A&W Food Services Reports Q3 2025 Financial Performance Insights
• Approval of BRINSUPRI™: A Transformation in NCFB Treatment
• Huntington Bancshares Reports Impressive Q3 Earnings Growth